The accurate definition and staging of chronic kidney disease (CKD) is one of the major
achievements of modern nephrology. Intensive research is now being undertaken to unravel …

Abstract Cardiac miRNAs (miR-1, miR133a, miR-208a/b, and miR-499) are abundantly
expressed in the myocardium. They play a central role in cardiogenesis, heart function and …

The National Kidney Foundation–Kidney Disease Outcomes Quality Initiative (NKF-KDOQI)
guideline for evaluation, classification, and stratification of chronic kidney disease (CKD) …

This document was approved by the American College of Cardiology Foundation (ACCF)
Board of Trustees in August 2012 and by the following societies in August 2012: American …

Chronic kidney disease (CKD) is a major public health problem. The classification of CKD by
KDOQI and KDIGO and the routine eGFR reporting have resulted in increased identification …

Background: MicroRNAs (miRNAs) are endogenous small RNAs of 21–25 nucleotides that
can pair with sites in 3′ untranslated regions in mRNAs of protein-coding genes to …

Heart failure remains a continuing threat to patients with chronic kidney disease (CKD).
Although various heart failure biomarkers have been applied for early detection, diagnosis …

Mortality among patients with ESRD remains high because of an excessive cardiovascular
risk related to a very high incidence of cardiac hypertrophy, cardiomyopathy, heart failure …

Background: Clinicians face uncertainty about the prognostic value of troponin testing in
patients with chronic kidney disease (CKD) without suspected acute coronary syndrome …

Background/Aims: Recent studies have shown that circulating microRNAs (miRNAs) are
emerging as promising biomarkers for cardiovascular diseases. This study aimed to …